Radiotherapie bei limited SCLC

By Müller A.-C.   Dunst J.  

Der Onkologe, Vol. 10, Iss. 4, 2004-04 ,pp. : 409-418

Springer Publishing Company

Access to resources Recommend Favorite

Combined Modality Treatment in Small Cell Lung Cancer (SCLC)

By Gregor A.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 816-818

Elsevier

Access to resources Recommend Favorite

A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice

By Kiaris H.   Schally A.V.   Nagy A.   Szepeshazi K.   Hebert F.   Halmos G.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 620-628

Elsevier

Access to resources Recommend Favorite

Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimens

By Burger H.   den Bakker M.A.   Stoter G.   Verweij J.   Nooter K.  

European Journal of Cancer, Vol. 39, Iss. 6, 2003-04 ,pp. : 793-799

Elsevier

Access to resources Recommend Favorite

Somatostatin Receptor Imaging of Small Cell Lung Cancer (SCLC) by Means of 111 In-DTPA Octreotide Scintigraphy

By Bombardieri E.   Crippa F.   Cataldo I.   Chiti A.   Seregni E.   Soresi E.   Boffi R.   Invernizzi G.   Buraggi G.L.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 184-188

Elsevier

Access to resources Recommend Favorite